BlackRock Innovation and Growth Term Trust (BTX)
NYSE: BTX · Real-Time Price · USD
7.66
-0.20 (-2.54%)
Feb 21, 2025, 4:00 PM EST - Market closed
Company Description
BlackRock Innovation and Growth Term Trust is a mutual fund launched by BlackRock, Inc. and managed by BlackRock Advisors, LLC. BlackRock Innovation and Growth Term Trust is based in United States.
BlackRock Innovation and Growth Term Trust
| Country | United States |
| Industry | Biotechnology |
| Sector | Healthcare |
Contact Details
Address: 50 Hudson Yards New York, New York 10001 United States | |
| Phone | 212 810 5300 |
Stock Details
| Ticker Symbol | BTX |
| Exchange | NYSE |
| Reporting Currency | USD |
| CIK Code | 0000748592 |
| CUSIP Number | 114082100 |
| ISIN Number | US1140821000 |
| Employer ID | 94-3127919 |
Key Executives
| Name | Position |
|---|---|
| Dr. Matthew Angel Ph.D. | Chief Executive Officer and Director |
| Dr. Roger Sidhu M.D. | Chief Medical Officer |
| Andrew C. Jackson | Chief Financial Officer |
| Dr. Monil Shah M.B.A., Pharm.D. | Chief Operating Officer |
| Sandra M. Gurrola | Principal Accounting Officer and Vice President of Finance |
| Lynn Sadowski Mason M.S. | Executive Vice President of Clinical Operations |
| Susan McClatchey | Vice President and Head of Quality |